Therefore, the therapeutic effect of sodium hyaluronate combined with RhEGF eye drops on xerophthalmia can also be achieved by reducing the rate of apoptotic cells and the secretion of TGFβ1 and TGFβ2 in the membrane of patients. This evidence concerns the gene TGFB2 and Keratoconjunctivitis sicca.